Peregrine Asset Advisers, Inc.

Position in KRYS — Krystal Biotech, Inc.

CIK 1535227 Portland, OR

Position in KRYS

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$203,303

New position

Shares Held

547

first reported quarter

Ownership

0.002%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#311

of 419 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Peregrine Asset Advisers, Inc. holds $789,611 across 5 Biotechnology names. KRYS ranks #3 (25.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	583	$289,593
2	RVMD	Revolution Medicines, Inc.	1,316	$246,460
3	KRYS	Krystal Biotech, Inc. This page	547	$203,303
4	CTMX	CytomX Therapeutics, Inc.	10,200	$38,250
5	TNYA	Tenaya Therapeutics, Inc.	16,245	$12,005

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$203,303	547	—	Shares	Sole	2026-08-10
No filing history on record for this holder in this stock.